Heart Failure-USB: Prediction and Progression
Recruiting now
Conditions studied: Acute Heart Failure, Acute Coronary Syndrome, Heart Failure
In brief
This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.
Key facts
- Study ID
- NCT04000061
- Run by
- University Hospital, Basel, Switzerland
- People needed
- 6000
- Starts
- 2019-06-13
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-04-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients hospitalized with a primary diagnosis of ACS
- Patients hospitalized with a primary or secondary diagnosis of AHF
You may not qualify if…
- Existence of a documented statement of the patient against the scientific use of clinical data
Where it is running
- Cardiology, University Hospital Basel — Basel, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.